Intestinal Ultrasound for Crohn's Disease: A Guide to Non-Invasive Monitoring

If you have Crohn's disease, you know the routine all too well: bowel prep, sedation, recovery days, and the lingering unease that comes with each colonoscopy or imaging appointment. For many of us, monitoring our disease can feel almost as exhausting as the disease itself. That is why intestinal ultrasound for Crohn's disease is generating so much excitement in the IBD community. This non-invasive, radiation-free tool is changing the way Crohn's is tracked - and it could change the way your next appointment feels, too.

What Is Intestinal Ultrasound?

Intestinal ultrasound (IUS) is a specialized imaging technique that uses high-frequency sound waves to visualize the bowel wall and detect inflammation in real time. Unlike the ultrasound you might associate with pregnancy scans or gallbladder checks, IUS is specifically designed to examine the layers of the intestinal wall and the surrounding tissue for signs of active Crohn's disease.

How It Differs from Standard Abdominal Ultrasound

A standard abdominal ultrasound gives a general picture of your organs - liver, kidneys, gallbladder. It is not designed to examine bowel wall structure in detail. Intestinal ultrasound, on the other hand, uses specialized techniques and probe positioning to measure bowel wall thickness, identify areas of active inflammation, and detect complications like strictures, abscesses, and fistulas. The gastroenterologist performing IUS is specifically trained to interpret these bowel-specific findings, making it a far more targeted and informative tool for IBD monitoring than a general ultrasound.

The Rise of Point-of-Care IUS in the United States

If you are in Europe, IUS may already be familiar to you. Gastroenterologists across the UK, Germany, Italy, and other European countries have been using intestinal ultrasound for decades as a routine part of IBD care. In the United States, adoption has been slower - but that is changing rapidly.

The American Gastroenterological Association (AGA) published its first clinical practice update on IUS for inflammatory bowel disease in 2024, formally recognizing its role in disease monitoring (3). This was a significant milestone. Meanwhile, the iUSCAN network and the Helmsley Charitable Trust have expanded US-based training programs since 2022, working to equip more American gastroenterologists with the skills to perform IUS at the point of care (5). Point-of-care means the ultrasound happens right there in the clinic during your regular appointment - no separate imaging center, no additional scheduling.

How Intestinal Ultrasound Works for Crohn's Monitoring

One of the most appealing things about IUS is how straightforward the experience is for patients. Understanding what to expect can help you feel more comfortable asking about it.

What Happens During the Procedure

The procedure is remarkably simple. During a routine clinic visit, your gastroenterologist places an ultrasound probe on your abdomen and examines your bowel in real time on a screen. There is no bowel prep required, no sedation, no IV contrast, and no special fasting. You lie on an exam table, some gel goes on your abdomen, and the scan typically takes 10 to 20 minutes (4).

Results are available immediately. Your doctor can discuss what they see with you right there in the room, which is a meaningful change from waiting days or weeks for imaging reports or biopsy results. For those of us who know the anxiety of waiting for test results, this immediacy can be a real relief.

What IUS Can Detect

IUS measures bowel wall thickness, which is one of the most reliable markers of intestinal inflammation. A thickened bowel wall indicates active disease, and tracking this measurement over time helps your doctor assess whether your treatment is working.

Beyond wall thickness, IUS can detect strictures (narrowed segments of bowel), abscesses (pockets of infection), and fistulas (abnormal connections between the bowel and other structures). It can also evaluate blood flow to the bowel wall using Doppler imaging, which provides additional information about inflammatory activity. This makes IUS valuable not just for a snapshot of your current disease state, but for tracking flare activity and treatment response over months and years.

Benefits Over Traditional Monitoring Methods

For a community that collectively endures countless colonoscopies, CT scans, and MRIs each year, the practical benefits of IUS are hard to overstate.

Compared to Colonoscopy

Colonoscopy remains the gold standard for certain tasks - cancer surveillance, tissue biopsy, and direct visualization of the mucosal surface. But for routine monitoring of known Crohn's disease, IUS offers significant advantages. There is no sedation, no bowel prep, no need to take a day off work for recovery, and no procedural risks like perforation or bleeding. Results are immediate rather than delayed.

A 2025 study found that point-of-care IUS reduced the need for endoscopy referrals from 39% to just 9% among IBD patients (2). That does not mean fewer colonoscopies when they are truly needed - it means fewer unnecessary ones, sparing patients the burden when ultrasound can provide the answers instead.

Compared to MRI and CT Scans

MRI enterography and CT enterography are powerful imaging tools, but they come with their own burdens. CT scans involve radiation exposure - a meaningful concern for Crohn's patients who may need repeated imaging over a lifetime. MRI requires no radiation but does involve fasting, IV contrast, and often drinking large volumes of oral contrast, plus the scan itself can take 45 minutes or more in a noisy, enclosed space.

The AGA's 2024 clinical practice update found that IUS matches the accuracy of both CT and MRI enterography for detecting bowel wall inflammation and complications in IBD (3, 4). That same 2025 study showed IUS reduced the need for additional cross-sectional imaging from 22% to just 4% (2). For routine monitoring, this means many patients can get the information they need without the time, cost, and discomfort of these larger imaging studies.

Safe During Pregnancy

For those navigating Crohn's disease during pregnancy, monitoring options become even more limited. CT scans are typically avoided due to radiation, and MRI, while generally considered safe, is used cautiously, particularly in the first trimester. IUS is completely radiation-free and requires no contrast agents, making it an especially valuable monitoring tool during pregnancy and for anyone who needs frequent imaging over time.

What the Latest Research Shows

The evidence supporting IUS continues to grow, and recent studies have focused not just on accuracy but on something equally important - the patient experience.

Patient Experience and Satisfaction

A 2026 multicenter study of 326 IBD patients examined how patients actually feel about intestinal ultrasound (1). The findings were encouraging: 69.9% of patients reported no discomfort during the procedure, and 60.7% preferred IUS over other monitoring methods they had experienced. Perhaps most tellingly, 46.1% of patients expressed stronger confidence in IUS results compared to blood work alone (43.8%), stool studies (35.6%), and other cross-sectional imaging (36.1%) (1).

These numbers matter because monitoring only works when patients actually follow through with it. A tool that patients are comfortable with and confident in is a tool that gets used consistently - and consistent monitoring is one of the most important factors in managing Crohn's disease effectively.

Impact on Clinical Decision-Making

Beyond patient comfort, IUS is proving to have a real impact on how doctors make treatment decisions. The 2025 study by Tan et al. found that point-of-care IUS reduced the need for stool testing from 51% to 9%, additional imaging from 22% to 4%, and endoscopy referrals from 39% to 9% (2). When IUS did reveal abnormal findings, it prompted treatment changes in 67% of symptomatic patients. This means IUS is helping doctors avoid both under-treatment (missing active disease) and over-treatment (escalating therapy unnecessarily), leading to more precise, personalized care.

This aligns with the broader movement toward non-invasive monitoring innovations for IBD, where the goal is to gather more frequent, accurate data with less burden on patients.

Limitations and What IUS Cannot Replace

As promising as intestinal ultrasound is, it is important to understand what it cannot do. IUS is a complementary tool, not a complete replacement for all other forms of monitoring.

Colonoscopy remains essential for cancer surveillance and for collecting tissue biopsies, which are sometimes needed to guide treatment decisions or rule out other conditions. IUS cannot perform these functions. Additionally, certain areas of the GI tract can be difficult to visualize with ultrasound - deep pelvic disease and some segments of the small bowel may not be adequately assessed, particularly in patients with a higher body mass index.

The accuracy of IUS also depends heavily on the skill and training of the person performing it. Not all gastroenterologists are trained in intestinal ultrasound yet, and there can be variability in image quality and interpretation between operators. As training programs expand and more centers adopt IUS, this limitation should diminish - but for now, it is a factor worth considering when seeking out this service.

IUS works best as part of a comprehensive monitoring strategy, used alongside - not instead of - colonoscopy, lab work, and other imaging when clinically indicated. Think of it as adding a powerful, low-burden tool to your monitoring toolkit rather than replacing the tools already there.

How to Ask Your Doctor About Intestinal Ultrasound

If you are interested in intestinal ultrasound, here are some practical steps and questions to bring to your next gastroenterology appointment.

Questions to ask your GI doctor:

• Is intestinal ultrasound available at your center or through a referral?
• Am I a candidate for IUS-based monitoring given my disease location and history?
• Could IUS reduce the frequency of colonoscopies or imaging scans I currently need?
• Are you trained in point-of-care IUS, or can you refer me to someone who is?

Where to find IUS:

Academic medical centers and IBD specialty clinics are currently the most likely places to offer intestinal ultrasound. If your gastroenterologist does not perform IUS, ask about referral options. The iUSCAN network maintains a directory of trained providers in North America and is a helpful starting resource (5).

Who benefits most:

IUS is most valuable for patients who are already diagnosed with Crohn's disease and in ongoing monitoring - tracking treatment response, watching for early signs of relapse, or assessing disease activity between colonoscopies. It is not typically used for the initial diagnosis of Crohn's disease, where colonoscopy with biopsy remains the standard approach.

Looking Ahead

Intestinal ultrasound represents a meaningful shift in how Crohn's disease monitoring can work - less invasive, more frequent, and centered around the patient experience. The evidence shows it is accurate, well-tolerated, and capable of reducing the burden of testing that many of us carry. As training programs expand and more centers adopt this technology, IUS is likely to become a routine part of Crohn's care across North America, much as it already is in Europe.

If you are tired of the prep, the waiting, and the recovery that come with traditional monitoring, it is worth having a conversation with your gastroenterologist about whether intestinal ultrasound could be part of your care plan. The more we advocate for accessible, patient-friendly tools, the closer we get to a monitoring experience that respects both our time and our well-being.

References

1. Gore, et al. The Patient Experience with Point-of-Care Intestinal Ultrasound for Inflammatory Bowel Disease Monitoring: A Multicenter Study. Digestive Diseases and Sciences, 2026. View on PubMed
2. Tan, et al. Point-of-Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional Investigations. Journal of Gastroenterology and Hepatology, 2025. View on PubMed
3. Chavannes, et al. AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary. Clinical Gastroenterology and Hepatology, 2024. View on PubMed
4. Cleveland Clinic. Point-of-Care Intestinal Ultrasound for Inflammatory Bowel Disease. Consult QD, 2024. Read article
5. iUSCAN. Intestinal Ultrasound is Shaping the Future of IBD Care. 2025. Read article